Skip to main content

Animations

MJFF Publications

3641 - 3650 of 6324 Results
Title
Year
  • Year
  • 2024
  • 2022
  • 2020
  • 2017
  • 2014
  • 2019
  • 2018
  • 2015
  • 2022
  • 2022
  • Summary Details
    OPEN
    Title: The clinical and genetic spectrum of inherited glycosylphosphatidylinositol deficiency disorders
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by, cc-by
    DOI - Digital Object Identifier: 10.1093/brain/awae056
    Citation Count: 7
  • Summary Details
    OPEN
    Title: Cathepsin B p.Gly284Val Variant in Parkinson’s Disease Pathogenesis
    Journal Name: International Journal of Molecular Sciences
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/ijms23137086
    Citation Count: 16
  • Summary Details
    OPEN
    Title: Purification of Recombinant α-synuclein: A Comparison of Commonly Used Protocols
    Journal Name: Biochemistry
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1021/acs.biochem.0c00725
    Citation Count: 21
  • Summary Details
    OPEN
    Title: Intra‐ and inter‐network functional alterations in Parkinson's disease with mild cognitive impairment
    Journal Name: Human Brain Mapping
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/hbm.23499
    Citation Count: 60
  • Summary Details
    OPEN
    Title: Diabetes mellitus is independently associated with more severe cognitive impairment in Parkinson disease
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2014.10.008
    Citation Count: 97
  • Summary Details
    OPEN
    Title: Defining α-synuclein species responsible for Parkinson’s disease phenotypes in mice
    Journal Name: Journal of Biological Chemistry
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1074/jbc.ra119.007743
    Citation Count: 114
  • Summary Details
    OPEN
    Title: Regional gray matter changes and age predict individual treatment response in Parkinson's disease
    Journal Name: NeuroImage: Clinical
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.nicl.2018.101636
    Citation Count: 25
  • Summary Details
    OPEN
    Title: Progressive dopaminergic alterations and mitochondrial abnormalities in LRRK2 G2019S knock-in mice
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.nbd.2015.02.031
    Citation Count: 246
  • Summary Details
    OPEN
    Title: Large-scale deep multi-layer analysis of Alzheimer’s disease brain reveals strong proteomic disease-related changes not observed at the RNA level
    Journal Name: Nature Neuroscience
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41593-021-00999-y
    Citation Count: 423
  • Summary Details
    OPEN
    Title: Lysosomal lipid alterations caused by glucocerebrosidase deficiency promote lysosomal dysfunction, chaperone-mediated-autophagy deficiency, and alpha-synuclein pathology
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-022-00397-6
    Citation Count: 59
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.